Alzheimer's Drug Discovery Foundation
@TheADDF
Followers
19K
Following
3K
Media
2K
Statuses
6K
The Alzheimer's Drug Discovery Foundation's mission is to rapidly accelerate the discovery and development of drugs to prevent, treat, and cure #Alzheimers.
New York, NY
Joined February 2009
We are deeply saddened to share the passing of ADDF Co-Founder Leonard A. Lauder. Alongside his brother, Leonard founded the ADDF in 1998, transforming the Alzheimer's research landscape through their vision, catalytic funding, venture philanthropy.
1
8
22
RT @WorldDementia: Join us 31 October for “Lessons from innovators: biomarkers.” Speakers include @a_hfillit, Stacie Weninger, Randall Bate….
0
4
0
New findings from the U.S. POINTER study showed that lifestyle changes like exercise, healthy eating & social connection can help protect brain health as we age. Learn more insights & tips on our Cognitive Vitality blog.
1
0
1
Healthcare startups are turning to venture philanthropy to advance bold ideas amid a challenging funding environment. Karen Harris shares how the ADDF bridges the gap with investments and a willingness to support high-risk, early-stage science. @cure345 .
wewillcure.com
At a time when federal funding is shrinking, healthcare startups are finding critical support from mission-driven venture philanthropies like the ADDF and LLS willing to back early-stage, high-risk...
0
0
2
Exciting news! @AlzData launched the global Alzheimer’s Insights AI Prize. This prize seeks AI solutions that can generate a powerful leap in the pace, scale, and reach of ADRD research.
🚀 Applications are open for the $1 million Alzheimer’s Insights AI Prize. Help develop the next agentic AI solution to accelerate research for more than 55 million people living with ADRD.
0
3
6
RT @WorldDementia: Coming soon: The World Dementia Council hosts a virtual dialogue on “Lessons from innovators: biomarkers” on 31 October.….
0
4
0
Dr. Fillit spotlights major advancements from AAIC like the U.S. POINTER study, innovation in the pipeline and new guidelines for blood biomarkers that are transforming #Alzheimer’s care through combination therapy and precision prevention. @NeurologyLive.
neurologylive.com
The cofounder and chief science officer of the Alzheimer's Drug Discovery Foundation recapped some of the notable recent developments in the Alzheimer disease field presented at the 2025 Alzheimer’s...
0
0
1
RT @AdrianNoriegaMD: Join us at this Year's House of Purple 💜! Help Support @TheADDF 's mission to prevent, treat & cure Alzheimer's 👇.
0
1
0
Save the date! The 4th Annual House of Purple is happening November 13 at #tribecarooftop360! Join us for a night of fun and networking as we honor Michelle Florin Canarick and support the ADDF's mission to #prevent #treat & #cure #Alzheimer's.
0
0
3
New 4-year CLARITY AD data show lecanemab slows decline & improves function in #Alzheimer’s. Dr. Fillit tells @Medscape this is a major advancement in reducing progression risk by 34%. This data brings us closer to precision medicine in Alzheimer’s care.
2
2
10
Each summer, the ADDF welcomes an amazing group of individuals to our internship program in partnership with LifeSci NYC. We are proud to spotlight the work of our 2025 interns, helping drive our mission forward to prevent, treat, and cure Alzheimer's.
0
0
1
New findings from ADDF board member & Goodes Prize winner @MiiaKivipelto show lifestyle changes may help delay #Alzheimer’s, especially for #APOE4 carriers. The future is precision prevention: personalized plans combining lifestyle & therapeutics. #AAIC25.
nbcnews.com
New research builds on previous evidence that diet, certain brain training exercises and physical activity can delay the decline of memory and other cognitive abilities.
1
2
6
New clinical guidelines for blood biomarkers mark a pivotal milestone. This is a first step in this effort, as they apply only to symptomatic patients in specialty care. As diagnostics evolve, updated guidance will be key to keeping pace with innovation.
1
0
3
RT @PhylFerrell: @TheADDF CEO, @TheADDFCEO Mark Roithmayr, addresses the attendees of the Alzheimer’s Impact Alliance, by thanking the #Alz….
0
4
0
ADDF board member, @PhylFerrell, shares with @Forbes her journey navigating her father’s Alzheimer’s diagnosis and how Alzheimer’s care and research have entered a new era driven by breakthroughs in treatments and diagnostics with recent FDA approvals.
forbes.com
New blood-based biomarker tests for amyloid and disease-modifying treatments have recently become available for Alzheimer's disease patients.
0
1
3
Congratulations to our friends and partners at Gates Ventures on their flagship publication from @_neuroproteome in @Nature, marking the global release of the GNPC harmonized dataset (v1), bringing us closer to how we detect, track and treat diseases like #Alzheimer’s.
Analyses from the largest neurodegeneration focused proteomics database - the Global Neurodegeneration Proteomics Consortium @_neuroproteome are published today in @NatureMedicine and @NatureAging. The findings reveal unique protein biomarkers that correlate with
0
1
2
What’s next for biotech in 2025? In @PMLiVEcom, Karen Harris dives into how market pressures are redefining breakthroughs in Alzheimer’s treatment with evolving funding shifts, policy changes and key investments.
pmlive.com
Short-term uncertainty is slowing investment activity, but the long-term outlook remains strong
0
0
0
Your brain changes as you age, but so can your habits. Yuko Hara shares with @HuffPost how our brains evolve with age, gaining wisdom and perspective, and why lifestyle interventions like diet play a crucial role in Alzheimer’s prevention.
huffpost.com
Doctors and nutrition experts share insights on the connection between food and brain health.
0
0
1
At #BIO2025, Karen Harris highlighted #biotech funding challenges, which started long before the NIH cuts, underscoring the urgent need for alternative capital pathways to sustain the biotech ecosystem. @cenmag .
cen.acs.org
Years into a biotech downturn, conference-goers focus on smaller deals
0
0
1